echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In March, more than half of the 15 pharmaceutical companies suffered a penalty loss of over 100 million yuan due to unqualified Ginkgo biloba extract or preparations

    In March, more than half of the 15 pharmaceutical companies suffered a penalty loss of over 100 million yuan due to unqualified Ginkgo biloba extract or preparations

    • Last Update: 2016-03-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In May 2015, CFDA found that some ginkgo biloba extract production enterprises had serious illegal behaviors in the flight inspection of Ginkgo biloba preparation API, that is, Ginkgo biloba extract production enterprises Subsequently, CFDA took a series of actions to deal with and rectify As of today, the Ginkgo biloba extract event is nearly a year old, but the event is still fermenting In March, 15 pharmaceutical companies were severely punished for failing to meet the requirements of Ginkgo biloba preparations and extracts, with a loss of more than 100 million yuan Before March 15, 2016, Shanxi Province imposed an administrative penalty on the enterprises that illegally produced and sold Ginkgo biloba preparations According to the unified deployment of the State Food and drug administration, Shanxi food and Drug Administration investigated and punished the enterprise Shanxi Qianyuan Pharmaceutical Group Co., Ltd., which illegally produced and sold Ginkgo biloba preparations The specific situation is as follows: 17 batches of ginkgo leaf dispersible tablets produced and sold by Shanxi Qianyuan Pharmaceutical Group Co., Ltd were inspected by Guangdong and other provincial drug inspection institutions, and 5 batches of ginkgo leaf dispersible tablets were identified as fake drugs due to their non-conforming test items; 12 batches of ginkgo leaf dispersible tablets were identified as substandard drugs due to their non-conforming test items of free quercetin, kaempferol and isorhamnetin However, the enterprise is able to actively report the situation of unqualified self inspection without any serious circumstances According to the provisions of Article 73 and 74 of the drug administration law of the people's Republic of China and Article 27 of the administrative penalty law of the people's Republic of China, the food and Drug Administration of Shanxi Province will impose such penalties as ordering it to stop production for rectification, confiscating the illegally produced products, illegal income and fines The total amount of administrative penalty is 4608700 yuan Hainan Food and Drug Administration imposed administrative penalties on two enterprises that illegally produced and sold Ginkgo biloba preparations Before March 11, 2016, according to the unified deployment of the food and drug administration, Hainan Food and Drug Administration investigated and punished two enterprises that illegally produced and sold Ginkgo biloba preparations, including Haikou Qili Pharmaceutical Co., Ltd The specific situation is as follows: 16 batches of Ginkgo leaves produced and sold by Haikou Qili Pharmaceutical Co., Ltd were inspected by Jilin and other provincial drug inspection institutions, and 8 batches of Ginkgo leaves were identified as fake drugs due to the non-conforming test items; 8 batches of Ginkgo leaves were identified as inferior drugs due to the non-conforming test items of free quercetin, kaempferol and isorhamnetin The food and Drug Administration of Hainan Province has transferred the suspected production and sale of fake drugs to the public security organ for investigation and handling according to law According to the provisions of Article 74 of the drug administration law of the people's Republic of China, the food and Drug Administration of Hainan Province imposed an administrative penalty of confiscating the illegally produced products, illegal income and fines on the enterprise, with a total fine of 1087008.4 yuan A batch of Ginkgo biloba dispersible tablets produced and sold by Hainan Haili Pharmaceutical Co., Ltd were tested by Chongqing food and Drug Inspection Institute The test items of free quercetin, kaempferol and isorhamnetin did not meet the requirements, so they were identified as inferior drugs According to Article 74 of the drug administration law of the people's Republic of China, the food and Drug Administration of Hainan Province imposed an administrative penalty of confiscating illegally produced products, illegal incomes and fines on the enterprise, with a total fine of 636435.36 yuan Hainan Food and Drug Administration imposed administrative penalties on two enterprises that illegally produced and sold Ginkgo biloba preparations Before March 11, 2016, according to the unified deployment of the food and drug administration, Hainan Food and Drug Administration investigated and punished two enterprises that illegally produced and sold Ginkgo biloba preparations, including Haikou Qili Pharmaceutical Co., Ltd The specific situation is as follows: 16 batches of Ginkgo leaves produced and sold by Haikou Qili Pharmaceutical Co., Ltd were inspected by Jilin and other provincial drug inspection institutions, and 8 batches of Ginkgo leaves were identified as fake drugs due to the non-conforming test items; 8 batches of Ginkgo leaves were identified as inferior drugs due to the non-conforming test items of free quercetin, kaempferol and isorhamnetin The food and Drug Administration of Hainan Province has transferred the suspected production and sale of fake drugs to the public security organ for investigation and handling according to law According to the provisions of Article 74 of the drug administration law of the people's Republic of China, the food and Drug Administration of Hainan Province imposed an administrative penalty of confiscating the illegally produced products, illegal income and fines on the enterprise, with a total fine of 1087008.4 yuan A batch of Ginkgo biloba dispersible tablets produced and sold by Hainan Haili Pharmaceutical Co., Ltd were tested by Chongqing food and Drug Inspection Institute The test items of free quercetin, kaempferol and isorhamnetin did not meet the requirements, so they were identified as inferior drugs According to Article 74 of the drug administration law of the people's Republic of China, the food and Drug Administration of Hainan Province imposed an administrative penalty of confiscating illegally produced products, illegal incomes and fines on the enterprise, with a total fine of 636435.36 yuan Zhejiang food and Drug Administration imposed an administrative penalty on the enterprises that illegally produced and sold Ginkgo biloba extract and preparations Before March 9, 2016, according to the unified deployment of the food and drug administration, Zhejiang food and Drug Administration investigated and punished Ningbo Lihua Pharmaceutical Co., Ltd., the enterprise that illegally produced and sold Ginkgo biloba extract and preparations Specific situation: Ningbo Lihua Pharmaceutical Co., Ltd purchased Ginkgo biloba extract and sold it in the name of the company Meanwhile, the purchased Ginkgo biloba extract was used in the production of Ginkgo biloba leaves The 63 batches of Ginkgo leaves produced by the enterprise were inspected by Ningbo Institute of pharmaceutical inspection and other inspection institutions The inspection items of free quercetin, kaempferol and isorhamnetin did not meet the requirements, so they were identified as inferior drugs There are also serious circumstances in the enterprise, such as changing product samples and avoiding supervision and inspection According to the provisions of Article 74 of the drug administration law of the people's Republic of China, Ningbo municipal market supervision and Administration Bureau of Zhejiang Province imposed an administrative penalty of confiscating the illegally produced products, illegal incomes and fines on the enterprise, with a total fine of 18290177.32 yuan At the same time, Li Weijun and Zhou Rong, two persons in charge of the enterprise, shall be punished according to law for their qualification of not engaging in drug production and trading activities within ten years The State Food and drug administration plans to revoke the approval documents of ginkgo leaf drugs of the enterprise according to law Liaoning food and Drug Administration imposed an administrative penalty on two enterprises that illegally produced and sold Ginkgo biloba preparations Before March 7, 2016, according to the unified deployment of the food and drug administration, Liaoning food and Drug Administration investigated and punished two enterprises that illegally produced and sold Ginkgo biloba preparations, including Liaoning xiancaotang Pharmaceutical Co., Ltd The specific situation is: two batches of ginkgo leaf soft capsules produced and sold by Liaoning xiancaotang Pharmaceutical Co., Ltd were inspected by China food and Drug Inspection Institute, and the inspection items of free quercetin, kaempferol and isorhamnetin did not meet the requirements, so they were identified as inferior drugs According to the provisions of Article 74 of the drug administration law of the people's Republic of China, the food and Drug Administration of Liaoning Province imposed an administrative penalty of confiscating illegally produced products, illegal incomes and fines on the enterprise, with a total fine of 1322309.3 yuan Four batches of ginkgo leaf soft capsules produced and sold by Liaoning Shengsheng Pharmaceutical Co., Ltd were found to be substandard in terms of free quercetin, kaempferol and isorhamnetin by Liaoning Provincial Institute of pharmaceutical inspection According to the provisions of Article 74 of the drug administration law of the people's Republic of China, the food and Drug Administration of Liaoning Province imposed an administrative penalty of confiscating illegally produced products, illegal incomes and fines on the enterprise, with a total penalty of 496514.45 yuan The food and Drug Administration of Guangxi Zhuang Autonomous Region imposed an administrative penalty on four enterprises illegally producing and selling Ginkgo biloba extract and preparations March 4, 2016 Recently, according to the unified deployment of the food and drug administration, the food and Drug Administration of Guangxi Zhuang Autonomous Region has investigated and punished four enterprises that illegally produce and sell Ginkgo biloba extract and preparations, including Guilin Xingda Pharmaceutical Co., Ltd The specific situation is: Guilin Xingda Pharmaceutical Co., Ltd purchases ginkgo leaf extract produced by unqualified enterprises to produce and sell fake medicine ginkgo leaf The illegal circumstances are serious According to the provisions of Article 73 of the drug administration law of the people's Republic of China, the pharmaceutical production license of the enterprise is revoked, the illegally produced products and illegal income are confiscated, and a fine is imposed At the same time, He Fei and Tao Yuliang, two persons in charge of the enterprise, shall be punished according to law for not being allowed to engage in drug production and marketing activities for ten years Guilin Honghui Pharmaceutical Co., Ltd produces and sells fake ginkgo leaf capsule and inferior ginkgo leaf, but it can actively report the situation of unqualified self inspection, etc without serious circumstances According to the provisions of Article 73 and article 74 of the drug administration law of the people's Republic of China, the illegally produced products and illegal income are confiscated and a fine is imposed Guangxi banzhou Dakang Pharmaceutical Co., Ltd produces and sells fake Ginkgo biloba leaves, but it is able to actively report the situation of unqualified self inspection, etc without serious circumstances According to the provisions of Article 73 of the drug administration law of the people's Republic of China, it will be given a warning, confiscated the illegal income and fined Guangxi Changzhou Natural Pharmaceutical Co., Ltd provides bills and other convenient conditions for others to operate Ginkgo biloba extract in the name of the company According to the provisions of Article 81 of the drug administration law of the people's Republic of China and Article 36 of the drug circulation supervision and administration measures, it shall be fined The food and Drug Administration of Guangxi Zhuang Autonomous Region has transferred the relevant cases to the public security organs and investigated the criminal responsibility according to law Hebei food and Drug Administration punished three drug manufacturers for using unqualified Ginkgo biloba extract to produce fake medicines and inferior drugs March 4, 2016 Recently, the food and Drug Administration of Hebei Province released the information disclosure form of the first batch of administrative penalty cases in 2016 Three pharmaceutical manufacturers, including Hebei Tiancheng Pharmaceutical Co., Ltd., were imposed administrative penalty for using unqualified Ginkgo biloba extract to produce fake or inferior drugs The details are as follows: Hebei Tiancheng Pharmaceutical Co., Ltd uses unqualified Ginkgo biloba extract to produce fake drugs According to Article 73 of the drug administration law of the people's Republic of China and paragraph 1 (1) of Article 27 of the administrative penalty law of the people's Republic of China, the illegal income of 150556 yuan is confiscated, and the fine of 159404 yuan twice the value of goods is reduced to 318808 yuan, with a total fine of 309960 yuan 。 Zhuozhou dongle Pharmaceutical Co., Ltd uses unqualified Ginkgo biloba extract to produce fake and inferior drugs According to the seventy-third article of the drug administration law of the People's Republic of China and the first paragraph (I) of the twenty-seventh article of the administrative penalty law of the People's Republic of China, the illegal income of 259589.8 yuan and the fake and inferior drugs illegally produced are confiscated, and a fine of 906951 yuan for two times of the value of goods is imposed and 1813092 is reduced To double, the total fine was 1166540.8 yuan Tangshan fule Pharmaceutical Co., Ltd uses unqualified Ginkgo biloba extract to produce fake drugs According to Article 73 of the drug administration law of the people's Republic of China and paragraph 1 (1) of Article 27 of the administrative penalty law of the people's Republic of China, the illegal income of 1169983.6 yuan and the fake drugs illegally produced are confiscated, and the goods value of 3189145.95 yuan is twice fined 6378291.9 yuan to be reduced To double, the total fine was 4359129.55 yuan.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.